ATE107922T1 - 2-(1-piperazinyl)-4-phenylcycloalkanpyridin- derivate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen, die sie enthalten. - Google Patents

2-(1-piperazinyl)-4-phenylcycloalkanpyridin- derivate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen, die sie enthalten.

Info

Publication number
ATE107922T1
ATE107922T1 AT90103244T AT90103244T ATE107922T1 AT E107922 T1 ATE107922 T1 AT E107922T1 AT 90103244 T AT90103244 T AT 90103244T AT 90103244 T AT90103244 T AT 90103244T AT E107922 T1 ATE107922 T1 AT E107922T1
Authority
AT
Austria
Prior art keywords
alkyl
hydrogen atom
piperazinyl
derivatives
preparation
Prior art date
Application number
AT90103244T
Other languages
English (en)
Inventor
Katsuhiko Hino
Naoki Kai
Masato Sakamoto
Tatsuya Kon
Makoto Oka
Kiyoshi Furakawa
Yoshiaki Ochi
Original Assignee
Dainippon Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co filed Critical Dainippon Pharmaceutical Co
Application granted granted Critical
Publication of ATE107922T1 publication Critical patent/ATE107922T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22Bridged ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT90103244T 1989-03-03 1990-02-20 2-(1-piperazinyl)-4-phenylcycloalkanpyridin- derivate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen, die sie enthalten. ATE107922T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5254489 1989-03-03

Publications (1)

Publication Number Publication Date
ATE107922T1 true ATE107922T1 (de) 1994-07-15

Family

ID=12917732

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90103244T ATE107922T1 (de) 1989-03-03 1990-02-20 2-(1-piperazinyl)-4-phenylcycloalkanpyridin- derivate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen, die sie enthalten.

Country Status (15)

Country Link
US (1) US5021421A (de)
EP (1) EP0385237B1 (de)
KR (1) KR0149649B1 (de)
AT (1) ATE107922T1 (de)
AU (1) AU623981B2 (de)
CA (1) CA2011346C (de)
DD (1) DD292909A5 (de)
DE (1) DE69010232T2 (de)
DK (1) DK0385237T3 (de)
ES (1) ES2058630T3 (de)
FI (1) FI94413C (de)
HK (1) HK1005872A1 (de)
HU (1) HU204810B (de)
NO (1) NO177095C (de)
RU (1) RU2075478C1 (de)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5041443A (en) * 1989-02-21 1991-08-20 Dainippon Pharmaceutical Co., Ltd. Medicament for treating cerebral insufficiency diseases, novel 2-(1-piperazinyl)-4-phenylcycloalkanopyrimidine derivatives, and process for the production thereof
DE69426771T2 (de) * 1993-06-25 2001-06-13 Pola Chemical Industries, Inc. Dopaminreinkorporationshemmer zur behandlung des parkinsonschen syndroms
CA2144669A1 (en) 1994-03-29 1995-09-30 Kozo Akasaka Biphenyl derivatives
US6458789B1 (en) 1999-09-29 2002-10-01 Lion Bioscience Ag 2-aminopyridine derivatives and combinatorial libraries thereof
CN1628109A (zh) * 2002-02-05 2005-06-15 诺沃挪第克公司 新颖的芳基-与杂芳基-哌嗪
EP1869000A1 (de) 2005-03-31 2007-12-26 Pfizer Products Incorporated Cyclopentapyridin- und tetrahydrochinolinderivate
CA2614116A1 (en) 2005-07-04 2007-01-11 Novo Nordisk A/S Novel medicaments
US8318927B2 (en) 2006-05-23 2012-11-27 High Point Pharmaceuticals, Llc 6-(4-cyclopropylpiperazin-1-yl)-2′-methyl-[3, 4′]-bipyridine and its uses as a medicament
CN102295606A (zh) 2006-05-29 2011-12-28 高点制药有限责任公司 合成3-(1,3-苯并间二氧杂环戊烯-5-基)-6-(4-环丙基哌嗪-1-基)-哒嗪的方法及其适用的中间体
MX2008015794A (es) * 2006-06-09 2009-01-12 Dainippon Sumitomo Pharma Co Preparacion de cinta novedosa.
PL2049529T3 (pl) * 2006-07-14 2011-01-31 Merck Sharp & Dohme Podstawione związki diazepanowe - antagoniści receptora oreksyny
PT2083811T (pt) 2006-11-22 2017-01-23 Clinical Res Ass Llc Métodos de tratamento da síndrome de down, síndrome do x frágil e autismo
EP2014656A3 (de) 2007-06-11 2011-08-24 High Point Pharmaceuticals, LLC Neue heterocyclische H3-Antagonisten
CN101531634B (zh) * 2008-03-10 2013-09-18 北京德众万全医药科技有限公司 一种高纯度的布南色林及其制备方法
CN101530412A (zh) * 2008-03-10 2009-09-16 北京德众万全医药科技有限公司 一种布南色林的药物组合物及其制备方法
CN101747273B (zh) * 2008-12-02 2012-03-07 浙江华海药业股份有限公司 布南色林中间体的制备方法
CN101747272B (zh) * 2008-12-02 2012-11-28 浙江华海药业股份有限公司 布南色林晶型b及其制备方法
CN101766626B (zh) * 2008-12-30 2012-03-07 丽珠医药集团股份有限公司 一种治疗精神分裂症的含布南色林的口服制剂
US20120121515A1 (en) 2009-03-13 2012-05-17 Lenny Dang Methods and compositions for cell-proliferation-related disorders
TWI598337B (zh) 2009-06-29 2017-09-11 阿吉歐斯製藥公司 治療化合物及組成物
CN101619039B (zh) * 2009-06-30 2011-04-13 严洁 2-(4-乙基-1-哌嗪基)-4-(4-氟苯基)-5,6,7,8,9,10-六氢芳辛并[b]吡啶及其组合物
EP3064595B1 (de) 2009-10-21 2019-02-27 Agios Pharmaceuticals, Inc. Verfahren für zellproliferationsbedingte erkrankungen
CA2793836C (en) 2009-10-21 2020-03-24 Agios Pharmaceuticals, Inc. Methods and compositions for cell-proliferation-related disorders
JP5881700B2 (ja) 2010-08-10 2016-03-09 ルピン・リミテッド ブロナンセリン経口放出制御型医薬組成物
CN102372673B (zh) * 2010-08-27 2014-04-09 天津市医药集团技术发展有限公司 布南色林结晶及其制备方法
CN102093289B (zh) * 2010-10-29 2012-12-19 常州华生制药有限公司 布南色林中间体的制备方法
CN102030707A (zh) * 2010-11-12 2011-04-27 深圳万和制药有限公司 布南色林中间体的制备方法
KR101873543B1 (ko) 2011-05-03 2018-07-02 아지오스 파마슈티컬스 아이엔씨. 치료에 사용하기 위한 피루베이트 키나아제 활성제
CN102827073A (zh) 2011-06-17 2012-12-19 安吉奥斯医药品有限公司 治疗活性组合物和它们的使用方法
CN102827170A (zh) * 2011-06-17 2012-12-19 安吉奥斯医药品有限公司 治疗活性组合物和它们的使用方法
CN115521264A (zh) 2012-01-06 2022-12-27 法国施维雅药厂 治疗活性化合物及其使用方法
US9474779B2 (en) 2012-01-19 2016-10-25 Agios Pharmaceuticals, Inc. Therapeutically active compositions and their methods of use
WO2014062511A1 (en) 2012-10-15 2014-04-24 Agios Pharmaceuticals, Inc. Therapeutic compounds and compositions
US9579324B2 (en) 2013-07-11 2017-02-28 Agios Pharmaceuticals, Inc Therapeutically active compounds and their methods of use
WO2015003355A2 (en) 2013-07-11 2015-01-15 Agios Pharmaceuticals, Inc. Therapeutically active compounds and their methods of use
WO2015003360A2 (en) 2013-07-11 2015-01-15 Agios Pharmaceuticals, Inc. Therapeutically active compounds and their methods of use
CN105593215B (zh) 2013-07-11 2019-01-15 安吉奥斯医药品有限公司 用于治疗癌症的作为idh2突变体抑制剂的2,4-或4,6-二氨基嘧啶化合物
US20150031627A1 (en) 2013-07-25 2015-01-29 Agios Pharmaceuticals, Inc Therapeutically active compounds and their methods of use
KR20220070066A (ko) 2014-03-14 2022-05-27 아지오스 파마슈티컬스 아이엔씨. 치료적으로 활성인 화합물의 약제학적 조성물
CN104311487B (zh) * 2014-09-22 2016-08-24 江苏正大丰海制药有限公司 一种布南色林晶型及其制备方法
MD3307271T2 (ro) 2015-06-11 2024-01-31 Agios Pharmaceuticals Inc Metode de utilizare a activatorilor de piruvat kinază
PL3362065T3 (pl) 2015-10-15 2024-09-16 Les Laboratoires Servier Terapia skojarzona zawierająca iwosidenib, cytarabinę i daunorubicynę lub idarubicynę do leczenia ostrej białaczki szpikowej
HRP20211790T1 (hr) 2015-10-15 2022-03-04 Les Laboratoires Servier Kombinirana terapija za liječenje maligniteta
KR20190028109A (ko) 2017-09-08 2019-03-18 연성정밀화학(주) 블로난세린 함유 서방성 제제
CN110575438A (zh) * 2018-06-07 2019-12-17 湖南省湘中制药有限公司 一种布南色林固体分散体的制备及其应用
US10980788B2 (en) 2018-06-08 2021-04-20 Agios Pharmaceuticals, Inc. Therapy for treating malignancies
WO2020184670A1 (ja) 2019-03-13 2020-09-17 大塚製薬株式会社 二級アミンを含有する化合物のアミン部分に重水素低級アルキルを導入する方法
CN113698346A (zh) * 2020-05-22 2021-11-26 湖南省湘中制药有限公司 一种布南色林工艺杂质b的制备方法
CN113698347A (zh) * 2020-05-22 2021-11-26 湖南省湘中制药有限公司 一种布南色林工艺杂质f的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54128588A (en) * 1978-03-29 1979-10-05 Dainippon Pharmaceut Co Ltd Antidepressive drugs consisting mainly of 2-(1-piperazinyl)- 4-phenylquinoline
DE3124673A1 (de) * 1981-06-24 1983-01-13 Bayer Ag, 5090 Leverkusen Subsituierte 2-amino-pyridinderivate, verfahren zu ihrer herstellung, ihre verwendung in arzneimitteln, sowie deren herstellung
FR2602771B1 (fr) * 1986-08-12 1988-11-04 Rhone Poulenc Sante Nouveaux derives de la benzyl-4 piperazine, leur preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
NO177095B (no) 1995-04-10
DE69010232D1 (de) 1994-08-04
CA2011346A1 (en) 1990-09-03
AU623981B2 (en) 1992-05-28
EP0385237A3 (de) 1991-03-20
NO900991L (no) 1990-09-04
DK0385237T3 (da) 1994-07-25
ES2058630T3 (es) 1994-11-01
RU2075478C1 (ru) 1997-03-20
HU204810B (en) 1992-02-28
NO900991D0 (no) 1990-03-01
HU901275D0 (en) 1990-05-28
EP0385237A2 (de) 1990-09-05
NO177095C (no) 1995-07-19
DE69010232T2 (de) 1994-12-01
DD292909A5 (de) 1991-08-14
AU5060490A (en) 1990-09-06
FI901030A0 (fi) 1990-03-01
EP0385237B1 (de) 1994-06-29
US5021421A (en) 1991-06-04
HUT53361A (en) 1990-10-28
KR900014358A (ko) 1990-10-23
HK1005872A1 (en) 1999-01-29
FI94413B (fi) 1995-05-31
CA2011346C (en) 1999-08-03
KR0149649B1 (ko) 1998-10-15
FI94413C (fi) 1995-09-11

Similar Documents

Publication Publication Date Title
ATE107922T1 (de) 2-(1-piperazinyl)-4-phenylcycloalkanpyridin- derivate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
PT88410A (pt) Process for preparing thiazolidinedione derivatives
ATE79376T1 (de) Dithioacetal-verbindungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE102193T1 (de) Thiazolidinedionederivate.
ATE185807T1 (de) Thiazolylbenzofuranderivate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen, die sie enthalten
GB8919417D0 (en) Novel compounds
ATE126216T1 (de) Pyrazolderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellung.
ATE52498T1 (de) Amidderivate.
ATE143355T1 (de) Pharmakologisch wirksame hydrazinderivate und verfahren zu deren herstellung
ATE57378T1 (de) 1(omega-(bis-(phenyl)-alkoxy>-alkyl)-4-(di(phenyl)-methyl)- piperazine, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
ATE123487T1 (de) Derivate der kaffeinsäure und sie enthaltende pharmazeutische zusammensetzungen.
AR035880A1 (es) Derivados de 5-tio-beta-d-xilopiranosida, proceso de preparacion y composiciones que los contengan
DK0434560T3 (da) Hidtil ukendte substituerede aminosyrederivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende dem
FR2655042B1 (fr) Nouvelles benzothiazolinones substituees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
ATE4313T1 (de) Tyrosin-derivate, verfahren zu deren herstellung und eine sie enthaltende pharmazeutische zusammensetzung zur behandlung von hypertonie.
GB920859A (en) Substituted triphenylmethanols
ATE3295T1 (de) Clavulansaeure-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
SI9111154B (sl) Novi ergolinski derivati 2-propinilamina, postopek za njihovo pripravo in njihova uporaba za zdravila
DE3784883D1 (de) Fluor enthaltende makrolid-verbindungen, pharmazeutische zusammensetzungen, welche diese enthalten und ihre verwendung fuer die herstellung von arzneimitteln.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEFA Change of the company name
EELA Cancelled due to lapse of time